About Careers MedBlog Contact us

Blood Test To Predict Anemia Risk Post Malaria Treatment

Font : A-A+

  • Anemia frequently affects patients treated for severe malaria with artemisinin drugs which kills malarial parasites.
  • But the deparasitized red blood cells retain the parasite histidine-rich protein 2 (HRP2).
  • HRP2 can be measured with a rapid diagnostic dipstick test that then can be used to predict the risk for delayed hemolysis and anemia.

  • Blood Test To Predict Anemia Risk Post Malaria Treatment

    An estimated 3.2 billion people in 95 countries are at risk of malaria infection, and even though treatment with a class of drugs called artemisinins is associated with fatality rates lower than 5%, some patients receiving these agents develop severe anemia weeks after clearance of the parasite.

    Researchers have adapted an existing diagnostic test for malaria to predict the dangerous complications that sometimes arise after the parasite is eradicated from patients' blood.

    Listen to this article

    Clinicians lack reliable methods to pinpoint which patients will experience widespread destruction of their red blood cells following therapy with the artemisinin artesunate - a condition called post-artesunate delayed hemolysis (PADH).

    Episodes of PADH have been linked with severe kidney failure, which is one reason why the World Health Organization has noted an urgent need for a simple and reliable test. Here, Papa Alioune Ndour and colleagues repurposed a diagnostic already in use - the BinaxNOW malaria kit - to predict PADH with 89% sensitivity and 73% specificity.

    The assay measures remnants of a malaria protein named HRP2 on red blood cells, and was successfully validated using diluted blood samples from 95 Bangladeshi patients and 53 French travelers, all of whom received artesunate.

    Notably, a separate cohort of 49 patients that were administered quinine (which is not associated with post-treatment anemia) did not have persistently high HRP2 levels. The authors say the accuracy of the test must be confirmed in larger-scale prospective studies, and may be preferable to current recommendations for mandatory 28-day monitoring of all malaria patients - to help high-risk patients achieve better post-treatment outcomes.

    Facts on Malaria

    • Over 40% of the world's population is at the risk of malaria, according to the WHO. There were almost 200 million recorded malaria cases in 2013, with around 584,000 of them resulting in fatalities.
    • In 2015, there were 212 million cases of malaria with a fall in global incidence by 21% between 2010 - 2015.
    • There was a 29% decrease in global malaria mortality rates between 2010 and 2015.
    • Malaria remains a major killer of under-fives, claiming the life of 1 child every 2 minutes.
    • Artemisinin-based combination therapies (ACTs) are highly effective against P. falciparum, the most prevalent and lethal malaria parasite affecting humans.
    1. Papa Alioune Ndour et al., Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis, Science Translational Medicine (2017).

    Source: Medindia

    Cite this Article   close



    Recommended Reading

    Latest Health Watch

     Nasal Ketamine Spray: A Breath of Relief for Chronic Migraine Sufferers
    Discover the potential of nasal ketamine spray as a safe and effective treatment for chronic migraine.
     Iron Deficiency and Mental Health: Why You Should Pay Attention
    Uncover the link between iron deficiency and mental health symptoms for better well-being.
    World Tobacco Day: We Need Food, Not Tobacco
    It is time to move from tobacco to food by nurturing sustainable crops for a healthier world.
    Empathy in Action: World MS Day Transforms Lives With Compassion
    World MS Day, is a global movement that ignites awareness, inspires hope, and celebrates the indomitable spirit of those affected by this complex condition.
    Irregular Periods can Put Your Heart at Risk
    Irregular menstrual cycles can significantly increase the risk of heart disease in women.
    View All
    This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

    Blood Test To Predict Anemia Risk Post Malaria Treatment Personalised Printable Document (PDF)

    Please complete this form and we'll send you a personalised information that is requested

    You may use this for your own reference or forward it to your friends.

    Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

    Name *

    Email Address *

    Country *

    Areas of Interests